Sitara-M 50 mg/500 mg Tablet

Product Introduction

Sitara-M 50 mg/500 mg Tablet is a combination medication used primarily in the management of Type 2 diabetes mellitus, a chronic condition characterized by high blood sugar levels. The tablet contains two active ingredients: Sitagliptin (50 mg) and Metformin (500 mg). Sitagliptin belongs to a class of drugs known as DPP-4 inhibitors (Dipeptidyl Peptidase-4 inhibitors), which work by regulating the levels of insulin the body produces after eating. Metformin is a biguanide, which helps reduce glucose production in the liver and improves the body’s sensitivity to insulin.

This combination tablet is particularly beneficial for patients who struggle to control their blood sugar levels with metformin alone or those who need an add-on therapy for better glycemic control. Sitara-M helps lower the risk of complications related to diabetes, such as heart disease, kidney damage, and nerve problems, by maintaining optimal blood sugar levels.

Sitara-M 50 mg/500 mg is typically prescribed alongside lifestyle changes like a healthy diet, regular exercise, and weight management. Its efficacy is maximized when patients follow a comprehensive diabetes care plan and monitor their blood sugar levels regularly.

Uses of Sitara-M 50 mg/500 mg Tablet

Sitara-M is primarily used to treat Type 2 diabetes mellitus. It is prescribed for patients who are not adequately controlled on metformin alone or who require combination therapy to improve blood sugar levels.

Specifically, it helps:

• Control high blood sugar levels: Sitara-M helps maintain blood glucose within the normal range by increasing insulin production in response to meals and decreasing sugar production in the liver.
• Prevent complications of diabetes: By keeping blood sugar levels in check, Sitara-M reduces the risk of developing long-term complications such as neuropathy (nerve damage), nephropathy (kidney damage), and retinopathy (eye damage).
• Improve overall health: By managing diabetes effectively, the medication contributes to a patient’s overall well-being and reduces the risk of cardiovascular problems.

Benefits of Sitara-M 50 mg/500 mg Tablet

• Effective glycemic control: Sitara-M provides dual action through its components, improving insulin response and lowering glucose production, which leads to better blood sugar regulation.
• Convenience: As a combination therapy, Sitara-M reduces the need for multiple medications, simplifying the treatment regimen.
• Weight-neutral effect: Unlike some diabetes medications that may cause weight gain, Sitara-M is considered weight-neutral, which is an advantage for patients concerned about their weight.
• Protection against diabetes complications: With better control of blood glucose levels, patients reduce their risk of experiencing serious diabetes-related complications such as heart disease, kidney problems, and vision issues.
• Reduction of HbA1c levels: Sitara-M has been shown to lower HbA1c (a measure of average blood glucose over the past 2-3 months), which is crucial for long-term diabetes management.
• Improved quality of life: Consistent blood sugar management leads to more energy, fewer diabetes-related symptoms, and a better overall quality of life.

Side Effects of Sitara-M 50 mg/500 mg Tablet

While Sitara-M is generally well-tolerated, some patients may experience side effects. Most side effects are mild and temporary, but some can be more serious. It is important to consult a healthcare provider if any adverse effects are persistent or concerning.

• Common side effects:
  • Nausea and vomiting: Some patients may experience gastrointestinal discomfort when starting Sitara-M.
  • Diarrhea: Metformin, one of the active ingredients, can cause loose stools or diarrhea, especially during the initial phase of treatment.
  • Abdominal pain: Mild to moderate stomach pain or discomfort is another common side effect.
  • Headache: Sitagliptin may cause headaches in some patients.
  • Respiratory infections: A few individuals may develop upper respiratory tract infections, like sore throat or nasal congestion.
• Serious but rare side effects:
  • Lactic acidosis: This is a rare but potentially life-threatening side effect of metformin, characterized by muscle pain, difficulty breathing, and severe tiredness. It requires immediate medical attention.
  • Pancreatitis: Sitagliptin may, in rare cases, lead to inflammation of the pancreas, which manifests as severe abdominal pain, nausea, and vomiting.
  • Hypoglycemia: While Sitara-M does not usually cause low blood sugar by itself, the risk of hypoglycemia (low blood sugar) may increase if it is taken alongside other antidiabetic drugs or insulin.
  • Allergic reactions: Some people may experience allergic reactions such as rash, itching, or swelling.